HIV REACTIVITY IN BLOOD DONORS AT TERTIARY CARE CENTRE PDU MEDICAL COLLEGE RAJKOT

Dr. Sanjay R. Talwelkar, Dr. Gauravi A. Dhruva, Dr. Sfoorti H. Goswami

Abstract


Background&objectives: India has the second highest HIV population in the world with about 2.5-3.0 million cases.Out of this 1.27 cases have
been reported from Gujarat. Cases among general and blood donor population have also been reported mostly from north-western and southern
states of India. This single centre study was carried out to observe the HIV reactivity among blood donors from Rajkot.
Methods: A total of 20,395 donors were screened for the presence of HIV infection over the 1-year period. All tests were done using the fourth
generation MERELISA ELISA kit which detected the presence of HIV-1 & HIV-2 P24 antigen and anti-HIV antibodies.
Results: A total of 22 (0.12%) donors were found to be repeat reactive for HIV. Of these all were males. Out of this 5 (22.7%) were nonreactive on
rapid tests.
Interpretation&conclusions: The prevalence of HIV was 0.12% per cent among blood donors of PDU medical college, Rajkot.


Keywords


HIV, donors, ELIS

Full Text:

PDF

References


UNAIDS Data Table 2011. [accessed on December 28, 2011]. Available from: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/JC2225_UNAIDS_datatables_en.pdf.

UNAIDS World AIDS Day Report 2011. [accessed on December 28, 2011]. Available from:

http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/JC2216_WorldAIDSday_report_2011_en.pdf.

[accessed on December 28, 2011]. Available from: http://www.unicef.org/india/hiv_aids_156.htm (UNICEF)

Kannangai R, Nair SC, Sridharan G, Prasannakumar S, Daniel D. Frequency of HIV type 2 infections among blood donor population from India: A 10-year experience. Indian J Med Microbiol. 2010;28:111–3. [PubMed] [Google Scholar]

Lange JM, Van den Berg H, Dooren LJ, Vossen LM, Kuis W, Goudsmit J. HTLV III/LAV infec-tion in nine children infected with a single plasma donor: clinical outcomes and recognition patterns of viral proteins. J Infect Dis. 1986;154:171–4. [PubMed] [Google Scholar]

The Gazette of India. New Delhi: Ministry of Health & Family Welfare; 1989. Ministry of Health & Family Welfare, Government of India (1989): Drugs and Cosmetics Act. [Google Scholar]

Allain JP. Genomic screening for blood borne viruses in transfusion settings. Clin Lab Haematol. 2000;22:1–10. [PubMed] [Google Scholar]

John TJ, Babu PG, Jeyakumari HM, Simoes EAF. Current prevalence and risk groups of HIV infection in Tamil Nadu, India. Lancet. 1987;1:160–1. [PubMed] [Google Scholar]

Simoes EA, Babu PG, Jeyakumari HM, John TJ. The Initial detection of Human Immunodeficiency virus 1 and its subsequent spread in Prostitutes in Tamil Nadu, India. J Acquir Immune Defic Syndr. 1993;6:1030–4. [PubMed] [Google Scholar]

Steinbrook R. HIV in India - A Complex Epidemic. N Engl J Med. 2007;356:1089–93. [PubMed] [Google Scholar]

Chandrasekaran P, Dallabetta G, Loo V, Rao S, Gayle H, Alexander A. Containing HIV/AIDS in India: the unfinished agenda. Lancet Infect Dis. 2006;6:508–21. [PubMed] [Google Scholar]

Smallman-Raynor M, Cliff A. The spread of human immunodeficiency virus type 2 into Europe: A geographical analysis. Int J Epidemiol. 1991;20:480–9. [PubMed] [Google Scholar]

Chattoraj A, Behl R, Kataria VK. Infectious disease markers in blood donors. Med J Armed Forces India. 2008;64:33–5. [PMC free article


Refbacks

  • There are currently no refbacks.